NCT00109564View on ClinicalTrials.gov

A Safety and Efficacy Study of Ispronicline (TC-1734-112) in Subjects With Age Associated Memory Impairment (AAMI)

PHASE2CompletedINTERVENTIONAL
Enrollment

174

Participants

Timeline

Start Date

January 31, 2005

Study Completion Date

October 31, 2005

Conditions
Age-Related Memory Disorders
Interventions
DRUG

ispronicline (nicotinic acetylcholine receptor agonist)

Trial Locations (15)

19115

Radiant Research Philadelphia, Philadelphia

27157

Wake Forest University, Winston-Salem

27408

Kulynych Research Center, Greensboro

30033

Northlake Medical Research Center, Decatur

33609

Meridien Research, Tampa

33709

Meridien Research, Saint Petersberg

33912

Neuropsychiatric Research Center of SW Florida, Fort Meyers

41042

Hartford Research, Florence

55404

Berman Center, Minneapolis

63141

Radiant Research, St Louis

78229

Radiant Research, San Antonio

80212

Radiant Research, Denver

84107

Radiant Research, Salt Lake City

85210

Pivotal Research Center, Mesa

85381

Pivotal Research Center, Peoria

All Listed Sponsors
lead

Targacept Inc.

INDUSTRY

NCT00109564 - A Safety and Efficacy Study of Ispronicline (TC-1734-112) in Subjects With Age Associated Memory Impairment (AAMI) | Biotech Hunter | Biotech Hunter